Filtered By:
Cancer: Prostate Cancer

This page shows you your search results in order of relevance. This is page number 13.

Order by Relevance | Date

Total 222 results found since Jan 2013.

Janssen Data at ASCO GU Demonstrate Longstanding Leadership in Prostate Cancer and Commitment to Advancing Potential New Therapeutic Options for Genitourinary Cancers
Raritan, NJ, Feb. 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that 17 presentations will be featured at the 2022 American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place in San Francisco and virtually from February 17-19. Building on its long-term leadership in prostate cancer, Janssen is committed to advancing innovative treatments and transforming patient experiences, while focusing on research that may drive better outcomes for people across the genitourinary cancer spectrum. Data to be presented include Phase 3 results for the selective ...
Source: Johnson and Johnson - February 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

New ERLEADA ® (apalutamide) Analysis Demonstrates Rapid, Deep Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
SAN FRANCISCO, Feb. 14, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new real-world evidence data showing the initiation of ERLEADA® (apalutamide) results in high rates of rapid and deep prostate-specific antigen (PSA) response among patients with metastatic castration-sensitive prostate cancer (mCSPC). In a separate post-hoc analysis of the registrational Phase 3 SPARTAN and TITAN studies, rapid and deep PSA responses with ERLEADA® were associated with improvement in patient-reported outcomes (PROs) related to quality of life, physical wellbeing, pain, and fatigue intensity. The...
Source: Johnson and Johnson - February 14, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

' Chipping away ' at the iceberg of health disparities
'Chipping away' at the iceberg of health disparities Kelly Palmer joined the Mel and Enid Zuckerman College of Public Health faculty in January, not long after earning her doctorate from the college. As a researcher studying diseases that disproportionately affect Black women, Palmer says her work is a team effort – and incredibly personal. Kyle Mittan Today University CommunicationsPalmer-web.jpg"Black women are my mother, my sister, my cousin, the members of my sorority, Alpha Kappa Alpha," said Kelly Palmer, an assistant professor in the University of Arizona Mel and Enid Zuckerman College of P...
Source: The University of Arizona: Health - February 14, 2022 Category: Universities & Medical Training Authors: mittank Source Type: research

NaF-PET reveals aortic wall injuries
PET imaging with F-18 sodium fluoride (NaF) can detect activity related to tear...Read more on AuntMinnie.comRelated Reading: NaF-PET scans reveal plaque -- and possible risk of stroke Viz.ai to add Avicenna.ai software to platform NaF-PET/CT does well in detecting prostate metastases NaF-PET/CT rarely finds prostate cancer bone metastases Can deep learning monitor lesions on F-18 NaF PET/CT?
Source: AuntMinnie.com Headlines - March 22, 2022 Category: Radiology Source Type: news

FDA says AI doesn't exclude LVO cases from radiologist review
Artificial intelligence (AI) software shouldn't be used to rule out cases o...Read more on AuntMinnie.comRelated Reading: FDA issues new draft cybersecurity guidance FDA issues warning on iodinated contrast use in young kids FDA approves Lu-177 PSMA-617 for prostate cancer treatment Report: Reimbursement drives adoption of AI software for stroke FDA proposes update to cybersecurity guidance
Source: AuntMinnie.com Headlines - April 11, 2022 Category: Radiology Source Type: news

Diffusion-Weighted MRI in the Genitourinary System
In conclusion, DWI constitutes a major advancement in genitourinary imaging with a central role in decision algorithms in the female pelvis and prostate cancer, now allowing promising applications in renal imaging or in the bladder and testicular mpMRI.PMID:35407528 | DOI:10.3390/jcm11071921
Source: Clinical Prostate Cancer - April 12, 2022 Category: Cancer & Oncology Authors: Thomas De Perrot Christine Sadjo Zoua Carl G Glessgen Diomidis Botsikas Lena Berchtold Rares Salomir Sophie De Seigneux Harriet C Thoeny Jean-Paul Vall ée Source Type: research

Successful treatment of an 82-year-old COVID-19 delta variant-infected patient with haemorrhagic stroke and active prostate cancer brain metastasis
Clin Transl Discov. 2022 Mar;2(1):e20. doi: 10.1002/ctd2.20. Epub 2022 Jan 12.NO ABSTRACTPMID:35464128 | PMC:PMC9015616 | DOI:10.1002/ctd2.20
Source: Clinical Prostate Cancer - April 25, 2022 Category: Cancer & Oncology Authors: Buhai Wang Jiangquan Yu Yichun Zeng Xian Zhang Chongxu Han Qili Lu Xiaolin Wang Yichen Liang Juan J Gu Yusheng Shu Source Type: research

ADT for Prostate Cancer: What ' s the Risk on the Heart? ADT for Prostate Cancer: What ' s the Risk on the Heart?
A new study found an increased risk of cardiovascular conditions, including stroke, as well as mortality in men with prostate cancer who receive androgen deprivation therapy.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - June 2, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Rapid MRI for ED stroke evaluation cuts costs, hospital length of stay
Using a rapid MRI protocol in the emergency department (ED) with people suspecte...Read more on AuntMinnie.comRelated Reading: Many significant imaging findings can be overlooked in ED patients Is neuroimaging overused for diagnosing dizziness? Short MRI comparable to CT for assessing interstitial lung disease Ultrashort brain MRI cost-effective compared to standard CT Short MRI exam shows promise for prostate cancer screening follow-up
Source: AuntMinnie.com Headlines - June 16, 2022 Category: Radiology Source Type: news

Health benefits of astaxanthin against age-related diseases of multiple organs: A comprehensive review
Crit Rev Food Sci Nutr. 2022 Jun 16:1-66. doi: 10.1080/10408398.2022.2084600. Online ahead of print.ABSTRACTAge-related diseases are associated with increased morbidity in the past few decades and the cost associated with the treatment of these age-related diseases exerts a substantial impact on social and health care expenditure. Anti-aging strategies aim to mitigate, delay and reverse aging-associated diseases, thereby improving quality of life and reducing the burden of age-related pathologies. The natural dietary antioxidant supplementation offers substantial pharmacological and therapeutic effects against various dise...
Source: Atherosclerosis - June 16, 2022 Category: Cardiology Authors: Phaniendra Alugoju V K D Krishna Swamy Naga Venkata Anusha Anthikapalli Tewin Tencomnao Source Type: research

Anemia is associated with increased risk of non-vertebral osteoporotic fractures in elderly men: the MrOS Sweden cohort
ConclusionsAnemia is associated with an increased risk for any fracture and non-vertebral osteoporotic fracture in elderly men with a long follow-up time. The cause is probably multifactorial and our results support that anemia can be used as a predictor for future fracture.
Source: Archives of Orthopaedic and Trauma Surgery - June 23, 2022 Category: Orthopaedics Source Type: research

ADT Use for Prostate Cancer Linked to Increased Risk for CVD Death
Risk increased for CVD death and for death from ischemic heart disease and stroke, especially among those aged 70 to 79 years
Source: The Doctors Lounge - Oncology - July 29, 2022 Category: Cancer & Oncology Tags: Cardiology, Internal Medicine, Oncology, Pharmacy, Urology, Geriatrics, Journal, Source Type: news